{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:11:13Z","timestamp":1763035873652},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2003,12,10]],"date-time":"2003-12-10T00:00:00Z","timestamp":1071014400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1007\/s00277-003-0792-0","type":"journal-article","created":{"date-parts":[[2004,3,19]],"date-time":"2004-03-19T13:27:09Z","timestamp":1079702829000},"page":"390-393","source":"Crossref","is-referenced-by-count":33,"title":["Rapid improvement of disseminated aspergillosis with caspofungin\/voriconazole combination in an adult leukemic patient"],"prefix":"10.1007","volume":"83","author":[{"given":"G.","family":"Damaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Le Brigand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"D\u2019incan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. F.","family":"Doglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Bilger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Faucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Vey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Gastaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,12,10]]},"reference":[{"key":"792_CR1","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1086\/513943","volume":"26","author":"Denning","year":"1998","unstructured":"Denning DW (1998) Invasive aspergillosis. Clin Infect Dis 26:781\u2013803, quiz 804\u2013805","journal-title":"Clin Infect Dis"},{"key":"792_CR2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0163-4453(98)80173-4","volume":"37","author":"Denning","year":"1998","unstructured":"Denning DW, Marinus A, Cohen J, et al. (1998) An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. J Infect 37:173\u2013180","journal-title":"J Infect"},{"key":"792_CR3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","volume":"32","author":"Lin","year":"2001","unstructured":"Lin SJ, Schranz J, Teutsch SM (2001) Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 32:358\u2013366","journal-title":"Clin Infect Dis"},{"key":"792_CR4","doi-asserted-by":"crossref","unstructured":"Patterson TF, Kirkpatrick WR, White M, et al. (2000) Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) 79:250\u2013260","DOI":"10.1097\/00005792-200007000-00006"},{"key":"792_CR5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0924-8579(00)00258-2","volume":"16","author":"Andriole","year":"2000","unstructured":"Andriole VT (2000) Current and future antifungal therapy: new targets for antifungal therapy. Int J Antimicrob Agents 16:317\u2013321","journal-title":"Int J Antimicrob Agents"},{"key":"792_CR6","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1086\/313756","volume":"30","author":"IDSA","year":"2000","unstructured":"IDSA (2000) Practice guidelines for diseases caused by aspergillus. Clin Infect Dis 30:696\u2013709","journal-title":"Clin Infect Dis"},{"key":"792_CR7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","volume":"347","author":"Herbrecht","year":"2002","unstructured":"Herbrecht R, Denning DW, Patterson TF, et al. (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408\u2013415","journal-title":"N Engl J Med"},{"key":"792_CR8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1345\/aph.1C114","volume":"37","author":"Pacetti","year":"2003","unstructured":"Pacetti SA, Gelone SP (2003) Caspofungin acetate for treatment of invasive fungal infections. Ann Pharmacother 37:90\u201398","journal-title":"Ann Pharmacother"},{"key":"792_CR9","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1128\/AAC.46.9.3039-3041.2002","volume":"46","author":"Perea","year":"2002","unstructured":"Perea S, Gonzalez G, Fothergill AW, Kirkpatrick WR, Rinaldi MG, Patterson TF (2002) In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp. Antimicrob Agents Chemother 46:3039\u20133041","journal-title":"Antimicrob Agents Chemother"},{"key":"792_CR10","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1128\/AAC.46.8.2564-2568.2002","volume":"46","author":"Kirkpatrick","year":"2002","unstructured":"Kirkpatrick WR, Perea S, Coco BJ, Patterson TF (2002) Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis. Antimicrob Agents Chemother 46:2564\u20132568","journal-title":"Antimicrob Agents Chemother"},{"key":"792_CR11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","volume":"34","author":"Ascioglu","year":"2002","unstructured":"Ascioglu S, Rex JH, de Pauw B, et al. (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34:7\u201314","journal-title":"Clin Infect Dis"},{"key":"792_CR12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1997.15.1.139","volume":"15","author":"Caillot","year":"1997","unstructured":"Caillot D, Casasnovas O, Bernard A, et al. (1997) Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 15:139\u2013147","journal-title":"J Clin Oncol"},{"key":"792_CR13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1439-0507.1999.00483.x","volume":"42","author":"Barnes","year":"1999","unstructured":"Barnes AJ, Oppenheim BA, Chang J, et al. (1999) Early investigation and initiation of therapy for invasive pulmonary aspergillosis in leukaemic and bone marrow transplant patients. Mycoses 42:403\u2013408","journal-title":"Mycoses"},{"key":"792_CR14","doi-asserted-by":"crossref","unstructured":"Adler-Moore JP, Chiang SM, Satorius A, et al. (1991) Treatment of murine candidosis and cryptococcosis with a unilamellar liposomal amphotericin B formulation (AmBisome). J Antimicrob Chemother 28 [Suppl B]:63\u201371","DOI":"10.1093\/jac\/28.suppl_B.63"},{"key":"792_CR15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/10428199709068287","volume":"27","author":"Mahlknecht","year":"1997","unstructured":"Mahlknecht U, von Lintig F, Mertelsmann R, et al. (1997) Successful treatment of disseminated central nervous aspergillosis in a patient with acute myeloblastic leukemia. Leuk Lymphoma 27:191\u2013194","journal-title":"Leuk Lymphoma"},{"key":"792_CR16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/clinids\/23.3.608","volume":"23","author":"Denning","year":"1996","unstructured":"Denning DW (1996) Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 23:608\u2013615","journal-title":"Clin Infect Dis"},{"key":"792_CR17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","volume":"347","author":"Herbrecht","year":"2002","unstructured":"Herbrecht R, Denning DW, Patterson TF, et al. (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408\u2013415","journal-title":"N Engl J Med"},{"key":"792_CR18","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jac\/dkf045","volume":"49","author":"Denning","year":"2002","unstructured":"Denning DW (2002) Echinocandins: a new class of antifungal. J Antimicrob Chemother 49:889\u2013891","journal-title":"J Antimicrob Chemother"},{"key":"792_CR19","unstructured":"Maertens J, Raad I, Sable CA, et al. (2000) Multicenter noncomparative study to evaluate safety and efficacy of caspofungin in adults with invasive aspergillosis refractory or intolerant to amphotericin B, amB lipid formulations or azoles (abstract 1103:371). 40th ICAAC, Toronto, Ontario, Canada, 17\u201320 September 2000"},{"key":"792_CR20","first-page":"90","volume":"12","author":"Gatbois","year":"2002","unstructured":"Gatbois E, Adjaoud D, Larroquet M, et al. (2002) Successful treatment of disseminated aspergillosis by caspofungin and voriconazole in a leukemic child. J Mycol Med 12:90\u201392","journal-title":"J Mycol Med"},{"key":"792_CR21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1046\/j.1365-2141.1997.972911.x","volume":"97","author":"Schwartz","year":"1997","unstructured":"Schwartz S, Milatovic D, Thiel E (1997) Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia. Br J Haematol 97:663\u2013665","journal-title":"Br J Haematol"},{"key":"792_CR22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1086\/314042","volume":"31","author":"Nesky","year":"2000","unstructured":"Nesky MA, McDougal EC, Peacock JE Jr (2000) Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis. Clin Infect Dis 31:673\u2013677","journal-title":"Clin Infect Dis"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-003-0792-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-003-0792-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-003-0792-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:44:44Z","timestamp":1559036684000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-003-0792-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12,10]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["792"],"URL":"https:\/\/doi.org\/10.1007\/s00277-003-0792-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12,10]]}}}